Which Medical Marijuana Model Would France Choose?

By, Aurelien Bernard France has created a governmental scientific committee comprising experts in neurology, sociology, pain management, HIV/AIDS, and public drug policies to evaluate whether medical cannabis should be available. This panel, the Temporary Scientific Specialist Committee (CSST), is charged with determining whether to approve medical cannabis, and if approved, to draft a regulatory framework. France […]